Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system.
• A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year.
• MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers).
Locations
United States
Texas
MD Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
Kate Hutcheson, PHD
karnold@mdanderson.org
713-792-6513
Time Frame
Start Date: 2025-06-01
Estimated Completion Date: 2029-01-31
Participants
Target number of participants: 85
Treatments
Experimental: Control Arm 1
The control arm will receive no active implementation strategy.
Experimental: Training Arm 2
Represents a low intensity implementation strategy solely using the DIGEST training program as the intervention.
Experimental: Training + Practice Facilitation Arm 3
Represents a higher intensity strategy using the same training program plus practice facilitation.
Related Therapeutic Areas
Sponsors
Leads: M.D. Anderson Cancer Center